Patent details

Basic Information

Publication number:

EP3234193

PCT Application Number:

US2015067143

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP158329342

PCT Publication Number:

WO2016100975

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MOLECULAR BIOMARKERS FOR CANCER IMMUNOTHERAPY

French Title of Invention:

BIOMARQUEURS MOLÉCULAIRES POUR L'IMMUNOTHÉRAPIE D'UN CANCER

German Title of Invention:

MOLEKULARE BIOMARKER FÜR KREBSIMMUNTHERAPIE

SPC Number:

Dates

Filing date:

21/12/2015

Grant date:

15/07/2020

EP Publication Date:

25/10/2017

PCT Publication Date:

23/06/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/07/2020

EP B1 Publication Date:

15/07/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/12/2020

Expiration date:

21/12/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/07/2020

 

 

Name:

Massachusetts Institute of Technology

Address:

77 Massachusetts Avenue, Cambridge, MA 02142, United States (US)

Name:

The General Hospital Corporation

Address:

55 Fruit Street, Boston, MA 02114, United States (US)

Inventor

1

Name:

ROONERY, Michael, S.

Address:

United States (US)

2

Name:

HACOHEN, Nir

Address:

United States (US)

Priority

Priority Number:

201462124473 P

Priority Date:

19/12/2014

Priority Country:

United States (US)

Classification

IPC classification:

G01N 33/574; C12Q 1/68;

Publication

European Patent Bulletin

Issue number:

202029

Publication date:

15/07/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages